tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal and mci 9038

tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal has been researched along with mci 9038 in 1 studies

Compound Research Comparison

Studies (tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal)	Trials (tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal)	Recent Studies (post-2010) (tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal)	Studies (mci 9038)	Trials (mci 9038)	Recent Studies (post-2010) (mci 9038)
16	0	0	1,087	83	349

Protein Interaction Comparison

Protein	Taxonomy	tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal (IC50)	mci 9038 (IC50)
Prothrombin	Homo sapiens (human)		0.22

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Callas, DD; Fareed, J	1

Other Studies

1 other study(ies) available for tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal and mci 9038

Article	Year
Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy. Thrombosis research, 1995, Jun-01, Volume: 78, Issue:5 Topics: Antifibrinolytic Agents; Antithrombin III; Antithrombins; Aprotinin; Arginine; Binding Sites; Boron Compounds; Enzyme Activation; Fibrinolysis; Heparin; Hirudins; Humans; Oligopeptides; Peptide Fragments; Pipecolic Acids; Protein C; Recombinant Proteins; Sulfonamides; Thrombin	1995

Article

Year

Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy.

Thrombosis research, 1995, Jun-01, Volume: 78, Issue:5

Topics: Antifibrinolytic Agents; Antithrombin III; Antithrombins; Aprotinin; Arginine; Binding Sites; Boron Compounds; Enzyme Activation; Fibrinolysis; Heparin; Hirudins; Humans; Oligopeptides; Peptide Fragments; Pipecolic Acids; Protein C; Recombinant Proteins; Sulfonamides; Thrombin

1995